VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

Dr. Barber on Surgical Readmission and Survival in Ovarian Cancer

Emma Barber, MD
Published: Sunday, Mar 12, 2017



Emma Barber, MD, UNC Department of Obstetrics and Gynecology, UNC School of Medicine, UNC Lineberger Comprehensive Cancer Center, discusses surgical readmission and survival in patients with ovarian cancer.

There has been a big push to decrease readmissions to hospitals for patients due to the Affordable Care Act, explains Barber. This is challenging for patients with ovarian cancer due to the difference between short-term and long-term morbidity.

Aggressive surgery for these patients is associated with more complications but long-term outcomes. Neoadjuvant chemotherapy has been shown to decrease surgical morbidity, lowering the complication rates and risk of death.
 


Emma Barber, MD, UNC Department of Obstetrics and Gynecology, UNC School of Medicine, UNC Lineberger Comprehensive Cancer Center, discusses surgical readmission and survival in patients with ovarian cancer.

There has been a big push to decrease readmissions to hospitals for patients due to the Affordable Care Act, explains Barber. This is challenging for patients with ovarian cancer due to the difference between short-term and long-term morbidity.

Aggressive surgery for these patients is associated with more complications but long-term outcomes. Neoadjuvant chemotherapy has been shown to decrease surgical morbidity, lowering the complication rates and risk of death.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Best Practice™: Expert Perspectives to Incorporate Evidence on PARP Inhibitors into Practice and Optimize the Medical Management of Ovarian CancerOct 31, 20181.0
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x